A Comprehensive Tyrosine Phosphoproteomic Analysis Reveals Novel Components of the Platelet CLEC-2 Signaling Cascade

被引:22
|
作者
Izquierdo, Irene [1 ,2 ]
Barrachina, Maria N. [1 ,2 ]
Hermida-Nogueira, Lidia [1 ,2 ]
Casas, Vanessa [3 ]
Moran, Luis A. [1 ,2 ]
Lacerenza, Serena [4 ]
Pinto-Llorente, Roberto [3 ]
Eble, Johannes A. [5 ]
de los Rios, Vivian [6 ]
Dominguez, Eduardo [1 ,2 ]
Loza, Maria, I [1 ,2 ]
Ignacio Casal, Jose [6 ]
Carrascal, Montserrat [3 ]
Abian, Joaquin [3 ]
Garcia, Angel [1 ,2 ]
机构
[1] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Avda Barcelona S-N, Santiago De Compostela 15782, Spain
[2] IDIS, Santiago De Compostela, Spain
[3] Spanish Natl Res Council IIBB CSIC IDIBAPS, Inst Biomed Res Barcelona, CSIC UAB Prote Lab, Barcelona, Spain
[4] Univ Pisa, Dept Pharm, Pisa, Italy
[5] Univ Munster, Inst Physiol Chem & Pathobiochem, Munster, Germany
[6] CSIC, Prote Facil, CIB, Madrid, Spain
基金
欧盟地平线“2020”;
关键词
platelets; CLEC-2; signaling; tyrosine phosphoproteome; COLLAGEN RECEPTOR; INTEGRIN ALPHA(IIB)BETA(3); PHOSPHOLIPASE C-GAMMA-2; PROTEOMIC ANALYSIS; ACTIVATION MOTIF; GLYCOPROTEIN VI; ADAPTER PROTEIN; PHOSPHORYLATION; SYK; ROLES;
D O I
10.1055/s-0039-3400295
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C-type lectin-like receptor 2 (CLEC-2) plays a crucial role in different platelet-related physiological and pathological processes. It signals through a tyrosine kinase-mediated pathway that is highly dependent on the positive feedback exerted by the platelet-derived secondary mediators, adenosine diphosphate (ADP) and thromboxane A (2) (TXA (2) ). Here, we aimed to analyze the tyrosine phosphoproteome of platelets activated with the CLEC-2 agonist rhodocytin to identify relevant phosphorylated tyrosine residues (p-Tyr) and proteins involved in platelet activation downstream of this receptor. We identified 363 differentially p-Tyr residues, corresponding to the majority of proteins previously known to participate in CLEC-2 signaling and also novel ones, including adaptors (e.g., DAPP1, Dok1/3, CASS4, Nck1/2), kinases/phosphatases (e.g., FAK1, FES, FGR, JAK2, SHIP2), and membrane proteins (e.g., G6F, JAM-A, PECAM-1, TLT-1). To elucidate the contribution of ADP and TXA (2) at different points of the CLEC-2 signaling cascade, we evaluated p-Tyr levels of residues identified in the analysis and known to be essential for the catalytic activity of kinases Syk(p-Tyr (525+526) ) and Src(p-Tyr (419) ), and for PLC gamma 2 activity (p-Tyr (759) ). We demonstrated that Syk phosphorylation at Tyr (525+526) also happens in the presence of ADP and TXA (2) inhibitors, which is not the case for Src-pTyr (419) and PLC gamma 2-pTyr (759) . Kinetics studies for the three phosphoproteins show some differences in the phosphorylation profile. Ca (2+) mobilization assays confirmed the relevance of ADP and TXA (2) for full CLEC-2-mediated platelet activation. The present study provides significant insights into the intracellular events that take place following CLEC-2 activation in platelets, contributing to elucidate in detail the CLEC-2 signalosome.
引用
收藏
页码:262 / 276
页数:15
相关论文
共 50 条
  • [21] A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2
    Suzuki-Inoue, K
    Fuller, GLJ
    García, A
    Eble, JA
    Pöhlmann, S
    Inoue, O
    Gartner, TK
    Hughan, SC
    Pearce, AC
    Laing, GD
    Theakston, RDG
    Schweighoffer, E
    Zitzmann, N
    Morita, T
    Tybulewicz, VLJ
    Ozaki, Y
    Watson, SP
    BLOOD, 2006, 107 (02) : 542 - 549
  • [22] Control of Platelet CLEC-2-Mediated Activation by Receptor Clustering and Tyrosine Kinase Signaling
    Martyanov, Alexey A.
    Balabin, Fedor A.
    Dunster, Joanne L.
    Panteleev, Mikhail A.
    Gibbins, Jonathan M.
    Sveshnikova, Anastasia N.
    BIOPHYSICAL JOURNAL, 2020, 118 (11) : 2641 - 2655
  • [23] A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways
    Mukherji, Mridul
    Brill, Laurence M.
    Ficarro, Scott B.
    Hampton, Garret M.
    Schultz, Peter G.
    BIOCHEMISTRY, 2006, 45 (51) : 15529 - 15540
  • [24] Suppression of platelet aggregation and tumor metastasis by anti-podoplanin mAbs recognizing a novel CLEC-2 binding domain
    Sekiguchi, Takaya
    Takemoto, Ai
    Fujita, Naoya
    CANCER RESEARCH, 2016, 76
  • [25] The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade
    Fuller, Gemma L. J.
    Williams, Jennifer A. E.
    Tomlinson, Michael G.
    Eble, Johannes A.
    Hanna, Sheri L.
    Pohlmann, Stefan
    Suzuki-Inoue, Katsue
    Ozaki, Yukio
    Watson, Steve P.
    Pearce, Andrew C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (17) : 12397 - 12409
  • [26] The Novel Platelet Activation Receptor CLEC-2 Regulates Blood/Lymphatic Vessel Separation by Inhibiting Proliferation and Migration of Lymphatic Endothelial Cells
    Osada, Makoto
    Inoue, Osamu
    Ding, Guo
    Hirashima, Masanori
    Suzuki-Inoue, Katsue
    Ozaki, Yukio
    BLOOD, 2010, 116 (21) : 74 - 74
  • [27] Signalling by the platelet C-type lectin receptor CLEC-2 is mediated by a novel mechanism involving Syk and a single YxxL motif.
    Pearce, AC
    Fuller, GLJ
    Suzuki-Inoue, K
    Tomlinson, MG
    Watson, SP
    BLOOD, 2005, 106 (11) : 115A - 115A
  • [28] Quantitative Circadian Phosphoproteomic Analysis of Arabidopsis Reveals Extensive Clock Control of Key Components in Physiological, Metabolic, and Signaling Pathways
    Choudhary, Mani Kant
    Nomura, Yuko
    Wang, Lei
    Nakagami, Hirofumi
    Somers, David E.
    MOLECULAR & CELLULAR PROTEOMICS, 2015, 14 (08) : 2243 - 2260
  • [29] Critical Role for an Acidic Amino Acid Region in Platelet Signaling by the HemITAM (Hemi-immunoreceptor Tyrosine-based Activation Motif) Containing Receptor CLEC-2 (C-type Lectin Receptor-2)
    Hughes, Craig E.
    Sinha, Uma
    Pandey, Anjali
    Eble, Johannes A.
    O'Callaghan, Christopher A.
    Watson, Steve P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (07) : 5127 - 5135
  • [30] Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2
    Kato, Yukinari
    Kaneko, Mika Kato
    Kunita, Akiko
    Ito, Hiromi
    Kameyama, Akihiko
    Ogasawara, Satoshi
    Matsuura, Nana
    Hasegawa, Yasushi
    Suzuki-Inoue, Katsue
    Inoue, Osamu
    Ozaki, Yukio
    Narimatsu, Hisashi
    CANCER SCIENCE, 2008, 99 (01) : 54 - 61